Tempo Therapeutics
A regenerative-medicine company developing injectable microporous scaffolds that help the body rebuild tissue at damaged sites.
$14.5MFunding
ParticipantGS
Gideon Strategic Partners
Activity from announced rounds
All recorded activity
Gideon Strategic Partners is the investment organization named in RADAR and Tempo financing coverage.
Recorded funding activity
RADAR combines RFID and computer vision for item-level retail inventory. Tempo develops injectable microporous scaffolds intended to support tissue regeneration. These records connect two distinct technical products to the same fully named investor.
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $184.5M 2 disclosed · full round size, not this investor’s share